priligy dapoxetine 30 mg (as hydrochloride) film-coated tablet blister pack
a menarini australia pty ltd - dapoxetine hydrochloride, quantity: 33.6 mg (equivalent: dapoxetine, qty 30 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; titanium dioxide; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; iron oxide yellow; microcrystalline cellulose; hypromellose; triacetin; iron oxide black - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: an intravaginal ejaculatory latency time (ielt) of less than two minutes; and persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and marked personal distress or interpersonal difficulty as a consequence of pe; and poor control over ejaculation.
dapoxetine ibn al haytham tablets film-coated
ibn al-haytham pharma industries co. - dapoxetine - tablets film-coated - 30mg
dapoxetine ibn al haytham tablets film-coated
ibn al-haytham pharma industries co. - dapoxetine - tablets film-coated - 60mg
priligy
a. menarini new zealand pty ltd - dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg; - film coated tablet - 30 mg - active: dapoxetine hydrochloride 33.6mg equivalent to dapoxetine 30 mg excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 4 lactose monohydrate as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-dried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.
priligy
a. menarini new zealand pty ltd - dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg; - film coated tablet - 60 mg - active: dapoxetine hydrochloride 67.2mg equivalent to dapoxetine 60 mg excipient: colloidal silicon dioxide croscarmellose sodium coating powder grey 3 lactose monohydrate as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose magnesium stearate microcrystalline cellulose as a spray-ried mixture of lactose monohydrate & microcrystalline cellulose - priligy is indicated for the treatment of premature ejaculation (pe) in men 18 to 64 years of age, who have all of the following: · persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and · marked personal distress or interpersonal difficulty as a consequence of pe; and · poor control over ejaculation.
priligy tablet 30mg
a. menarini singapore pte. ltd. - dapoxetine eqv to dapoxetine hydrochloride 33.60mg - tablet, film coated - 30mg - dapoxetine eqv to dapoxetine hydrochloride 33.60mg 30mg
priligy tablet 60mg
a. menarini singapore pte. ltd. - dapoxetine eqv to dapoxetine hydrochloride 67.20mg - tablet, film coated - 60mg - dapoxetine eqv to dapoxetine hydrochloride 67.20mg 60mg
plotis 30 mg film-coated tablets
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - dapoxetine - film-coated tablet - dapoxetine 30 mg - urologicals
plotis 60 mg film-coated tablets
medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - dapoxetine - film-coated tablet - dapoxetine 60 mg - urologicals
priligy 60 mg film-coat. tabl.
menarini benelux sa-nv - dapoxetine hydrochloride 67,2 mg - eq. dapoxetine 60 mg - film-coated tablet - 60 mg - dapoxetine hydrochloride 67.2 mg - dapoxetine